Schrodinger Inc (SDGR)
23.68
+0.49
(+2.11%)
USD |
NASDAQ |
May 03, 16:00
23.66
-0.02
(-0.06%)
After-Hours: 20:00
Schrodinger Research and Development Expense (Quarterly): 50.61M for March 31, 2024
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 50.61M |
| December 31, 2023 | 51.49M |
| September 30, 2023 | 46.83M |
| June 30, 2023 | 42.70M |
| March 31, 2023 | 40.74M |
| December 31, 2022 | 34.54M |
| September 30, 2022 | 32.88M |
| June 30, 2022 | 31.12M |
| March 31, 2022 | 27.82M |
| December 31, 2021 | 25.14M |
| September 30, 2021 | 23.22M |
| June 30, 2021 | 21.09M |
| Date | Value |
|---|---|
| March 31, 2021 | 21.45M |
| December 31, 2020 | 17.32M |
| September 30, 2020 | 17.02M |
| June 30, 2020 | 16.66M |
| March 31, 2020 | 13.70M |
| December 31, 2019 | 11.08M |
| September 30, 2019 | 10.35M |
| June 30, 2019 | 9.531M |
| March 31, 2019 | 8.438M |
| December 31, 2018 | 8.874M |
| September 30, 2018 | 8.82M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
9.531M
Minimum
Jun 2019
51.49M
Maximum
Dec 2023
27.27M
Average
24.18M
Median
Research and Development Expense (Quarterly) Benchmarks
| Simulations Plus Inc | 1.312M |
| Nano Mobile Healthcare Inc | -- |
| Optimus Healthcare Svcs Inc | -- |
| ORHub Inc | 0.5719M |
| Veeva Systems Inc | 163.56M |